Fludarabine as an Adjuvant Improves Newcastle Disease Virus-Mediated Antitumor Immunity in Hepatocellular Carcinoma
In addition to direct oncolysis, oncolytic viruses (OVs) also induce antitumor immunity, also called viro-immunotherapy. Limited viral replication and immune-negative feedback are the major hurdles to effective viro-immunotherapy. In this study, we found that use of an adjuvant of fludarabine, a che...
Main Authors: | Gang Meng, Ziwei Fei, Mingyue Fang, Binghua Li, Anxian Chen, Chun Xu, Mao Xia, Decai Yu, Jiwu Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Molecular Therapy: Oncolytics |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2372770519300348 |
Similar Items
-
CD8+ T cells mediate the antitumor activity of frankincense and myrrh in hepatocellular carcinoma
by: Chun Xu, et al.
Published: (2018-05-01) -
Liver-enriched Genes are Associated with the Prognosis of Patients with Hepatocellular Carcinoma
by: Binghua Li, et al.
Published: (2018-07-01) -
The Glutaminase-1 Inhibitor 968 Enhances Dihydroartemisinin-Mediated Antitumor Efficacy in Hepatocellular Carcinoma Cells.
by: Diancheng Wang, et al.
Published: (2016-01-01) -
An ultrasonic nanobubble-mediated PNP/fludarabine suicide gene system: A new approach for the treatment of hepatocellular carcinoma.
by: Bo Zhang, et al.
Published: (2018-01-01) -
An Immunogram for an Individualized Assessment of the Antitumor Immune Response in Patients With Hepatocellular Carcinoma
by: Ying Hu, et al.
Published: (2020-07-01)